Published in Am J Kidney Dis on July 01, 1997
Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden. Adv Chronic Kidney Dis (2008) 1.98
Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev (2012) 1.97
Cognitive function and all-cause mortality in maintenance hemodialysis patients. Am J Kidney Dis (2014) 1.56
Prevalence and correlates of cognitive impairment in hemodialysis patients: the Frequent Hemodialysis Network trials. Clin J Am Soc Nephrol (2010) 1.55
CKD associates with cognitive decline. J Am Soc Nephrol (2009) 1.55
A prospective study of albuminuria and cognitive function in older adults: the Rancho Bernardo study. Am J Epidemiol (2010) 1.52
Kidney function and cognitive performance and decline in older men. J Am Geriatr Soc (2008) 1.48
Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies. Kidney Int (2010) 1.47
Low 25-hydroxyvitamin D levels and cognitive impairment in hemodialysis patients. Clin J Am Soc Nephrol (2013) 1.44
Renal function and long-term decline in cognitive function: the Baltimore Longitudinal Study of Aging. Am J Nephrol (2015) 1.40
Cardiovascular disease and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis (2011) 1.35
Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology (2013) 1.34
Effect of more frequent hemodialysis on cognitive function in the frequent hemodialysis network trials. Am J Kidney Dis (2012) 1.26
Depression and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis (2010) 1.24
Cognitive impairment in peritoneal dialysis patients. Am J Kidney Dis (2011) 1.13
Decline in renal functioning is associated with longitudinal decline in global cognitive functioning, abstract reasoning and verbal memory. Nephrol Dial Transplant (2012) 1.06
Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study. Am J Kidney Dis (2009) 1.06
The kidney disease quality of life cognitive function subscale and cognitive performance in maintenance hemodialysis patients. Am J Kidney Dis (2012) 1.04
Cognitive profile of chronic kidney disease and hemodialysis patients without dementia. Nephron Clin Pract (2010) 1.01
Frailty and Cognitive Function in Incident Hemodialysis Patients. Clin J Am Soc Nephrol (2015) 1.00
Risk of dementia in peritoneal dialysis patients compared with hemodialysis patients. Perit Dial Int (2015) 0.98
Cognitive function and dialysis adequacy: no clear relationship. Am J Nephrol (2010) 0.93
Neurological complications of chronic kidney disease. Nat Rev Neurol (2009) 0.93
Frailty and mortality in dialysis: evaluation of a clinical frailty scale. Clin J Am Soc Nephrol (2015) 0.93
The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients. PLoS One (2014) 0.92
Relationship between conditions addressed by hemodialysis guidelines and non-ESRD-specific conditions affecting quality of life. Clin J Am Soc Nephrol (2009) 0.90
Nutritional Intake in Adult Hemodialysis Patients. Top Clin Nutr (2011) 0.82
Cognitive and physical function in chronic kidney disease. Curr Opin Nephrol Hypertens (2014) 0.81
Diffuse interstitial brain edema in patients with end-stage renal disease undergoing hemodialysis: a tract-based spatial statistics study. Medicine (Baltimore) (2014) 0.81
Measures of blood pressure and cognition in dialysis patients. Hemodial Int (2012) 0.80
Comparison of dementia risk between end stage renal disease patients with hemodialysis and peritoneal dialysis--a population based study. Sci Rep (2015) 0.79
Patient-reported cognitive functioning and daily functioning in chronic dialysis patients. Hemodial Int (2014) 0.78
25-vitamin D, 1,25-vitamin D, parathyroid hormone, fibroblast growth factor-23 and cognitive function in men with advanced CKD: a veteran population. Clin Nephrol (2014) 0.78
Structural and functional brain alterations in end stage renal disease patients on routine hemodialysis: a voxel-based morphometry and resting state functional connectivity study. PLoS One (2014) 0.77
Cognitive impairment and depression in a population of patients with chronic kidney disease in Colombia: a prevalence study. Can J Kidney Health Dis (2016) 0.77
Regional homogeneity changes in hemodialysis patients with end stage renal disease: in vivo resting-state functional MRI study. PLoS One (2014) 0.77
Habitual coffee consumption enhances attention and vigilance in hemodialysis patients. Biomed Res Int (2014) 0.77
FGF-23 and cognitive performance in hemodialysis patients. Hemodial Int (2013) 0.77
Indoxyl Sulfate Affects Glial Function Increasing Oxidative Stress and Neuroinflammation in Chronic Kidney Disease: Interaction between Astrocytes and Microglia. Front Pharmacol (2017) 0.77
Major barriers responsible for malnutrition in hemodialysis patients: challenges to optimal nutrition. Nephrourol Mon (2014) 0.76
Cognitive function among hemodialysis patients in Japan. Ann Gen Psychiatry (2011) 0.76
Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients. Am J Nephrol (2016) 0.75
Cognitive Decline and Its Risk Factors in Prevalent Hemodialysis Patients. Am J Kidney Dis (2017) 0.75
[Elderly patients on chronic hemodialysis: experience of a Moroccan hospital]. Pan Afr Med J (2013) 0.75
Cognitive Impairment in Chronic Kidney Disease: Vascular Milieu and the Potential Therapeutic Role of Exercise. Biomed Res Int (2017) 0.75
Prevalence and pattern of neurocognitive impairment in nigerians with stages 3 to 5 chronic kidney disease. ISRN Neurol (2013) 0.75
Related Factors and Predictors of Cognitive Dysfunction in Chronic Kidney Disease on Maintenance Hemodialysis in Nigeria. J Neurosci Rural Pract (2016) 0.75
Consequences of CKD on Functioning. Semin Nephrol (2016) 0.75
Kidney-brain crosstalk in the acute and chronic setting. Nat Rev Nephrol (2015) 0.75
Dementia and Alzheimer's Disease among Older Kidney Transplant Recipients. J Am Soc Nephrol (2016) 0.75
The Utility of the Mini-Addenbrooke's Cognitive Examination as a Screen for Cognitive Impairment in Elderly Patients with Chronic Kidney Disease and Diabetes. Dement Geriatr Cogn Dis Extra (2016) 0.75
Dementia is a risk factor for major adverse cardiac and cerebrovascular events in elderly Korean patients initiating hemodialysis: a Korean national population-based study. BMC Nephrol (2017) 0.75
Performance of the Modified Mini-Mental State Examination (3MS) in Assessing Specific Cognitive Function in Patients Undergoing Peritoneal Dialysis. PLoS One (2016) 0.75
The elderly patients on hemodialysis. Minerva Urol Nefrol (2010) 0.75
Cognitive changes associated with switching to frequent nocturnal hemodialysis or renal transplantation. BMC Nephrol (2016) 0.75
Effect of renal transplantation on cognitive function in hemodialysis patients: a longitudinal study. Int Urol Nephrol (2017) 0.75
Abnormal amyloid β42 expression and increased oxidative stress in plasma of CKD patients with cognitive dysfunction: A small scale case control study comparison with Alzheimer's disease. BBA Clin (2017) 0.75
A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. N Engl J Med (1992) 5.93
Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science (1982) 5.63
Evaluation of dementia. N Engl J Med (1996) 4.29
Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 3.74
Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol (1981) 3.18
The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective. JAMA (1997) 2.45
Donepezil and flight simulator performance: effects on retention of complex skills. Neurology (2002) 2.14
Emerging antidementia drugs: a preliminary ethical view. J Am Geriatr Soc (1998) 2.11
Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol (1983) 2.06
Fairhill guidelines on ethics of the care of people with Alzheimer's disease: a clinical summary. Center for Biomedical Ethics, Case Western Reserve University and the Alzheimer's Association. J Am Geriatr Soc (1995) 1.94
Speaking of research advance directives: planning for future research participation. Neurology (2006) 1.61
Quality of Life in Dementia: state of the art--report of the International Working Group for Harmonization of Dementia Drug Guidelines and the Alzheimer's Society satellite meeting. Alzheimer Dis Assoc Disord (2001) 1.60
Diseases of meaning, manifestations of health, and metaphor. J Altern Complement Med (1999) 1.56
Complex visual disturbances in Alzheimer's disease. Neurology (1990) 1.45
Situated beyond modernity: lessons for Alzheimer's disease research. J Am Geriatr Soc (1995) 1.44
A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 1.36
The concept of subcortical and cortical dementia: another look. Ann Neurol (1986) 1.30
Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease. Brain Res (1998) 1.26
Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res (1986) 1.26
Barriers to adequate delivery of hemodialysis. Am J Kidney Dis (1998) 1.24
Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy. Ann Neurol (1988) 1.17
Is the placebo control obsolete in a world after donepezil and vitamin E? Arch Neurol (1998) 1.16
The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol (1988) 1.16
Personality changes in Alzheimer's disease. Arch Neurol (1992) 1.15
Enhancing cognition in the intellectually intact. Hastings Cent Rep (1997) 1.13
Pathology in brainstem regions of individuals with primary dystonia. Neurology (1988) 1.13
Primary degenerative dementia without Alzheimer pathology. Can J Neurol Sci (1986) 1.13
Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 1.12
Abnormalities of the nucleus basalis in Down's syndrome. Ann Neurol (1985) 1.11
Loss of pedunculopontine neurons in progressive supranuclear palsy. Ann Neurol (1987) 1.08
Differential diagnosis of Alzheimer's disease. Neurology (1997) 1.06
Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease. Nature (1986) 1.05
A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 1.05
Cholinergic innervation in neuritic plaques. Science (1982) 1.02
Gender differences in language of AD patients: a longitudinal study. Neurology (1995) 1.02
Alzheimer's disease and Down's syndrome. Ann N Y Acad Sci (1982) 1.01
Munchausen's syndrome simulating torsion dystonia. N Engl J Med (1985) 0.99
Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes. Ann Neurol (1985) 0.96
Quality of life and dementia. Alzheimer Dis Assoc Disord (1992) 0.96
Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus. J Neurochem (1989) 0.94
Vinpocetine for cognitive impairment and dementia. Cochrane Database Syst Rev (2003) 0.94
Memory evaluation in Alzheimer's disease. Caregivers' appraisals and objective testing. Arch Neurol (1993) 0.92
Self-reported functional status: an important predictor of health outcomes among end-stage renal disease patients. Adv Ren Replace Ther (1999) 0.92
Ethical issues in Alzheimer disease: the experience of a national Alzheimer society task force. Alzheimer Dis Assoc Disord (1999) 0.92
Amyotrophic lateral sclerosis: alterations in neurotransmitter receptors. Ann Neurol (1983) 0.92
Topography of the magnocellular basal forebrain system in human brain. J Neuropathol Exp Neurol (1984) 0.91
Primary dystonias: a review of the pathology and suggestions for new directions of study. Adv Neurol (1988) 0.91
Cognitive impairment of Alzheimer disease. Neurobehav Toxicol Teratol (1984) 0.90
Alzheimer's dementia: performance on parallel forms of the dementia assessment battery. J Clin Exp Neuropsychol (1989) 0.90
The nucleus basalis in Huntington's disease. Neurology (1983) 0.90
Aminergic systems in Alzheimer's disease and Parkinson's disease. Ann Neurol (1987) 0.90
Reductions in corticotropin releasing factor-like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy. Neurology (1987) 0.90
Pick's disease (lobar sclerosis): depletion of neurons in the nucleus basalis of Meynert. Neurology (1983) 0.88
Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex. Brain Res (1987) 0.88
Retracted Concurrent measurement of plasma levels of vitamin D3 and five of its metabolites in normal humans, chronic renal failure patients, and anephric subjects. J Lab Clin Med (1981) 0.88
Effects of two nonsteroidal anti-inflammatory drugs, indomethacin and oxaprozin, on the kidney. Clin Pharmacol Ther (1980) 0.86
Alzheimer's disease and related dementias: selective involvement of specific neuronal systems. CRC Crit Rev Clin Neurobiol (1985) 0.86
Familial progressive subcortical gliosis. Neurology (1994) 0.86
Contrast sensitivity in Alzheimer's disease: a 1-year longitudinal analysis. Optom Vis Sci (1995) 0.86
Guidelines for addressing ethical and legal issues in Alzheimer disease research: a position paper. National Institute on Aging. Alzheimer Dis Assoc Disord (1994) 0.85
Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease. Adv Neurol (1987) 0.84
Assessment of behavioral and affective symptoms in Alzheimer's disease. J Geriatr Psychiatry Neurol (1990) 0.84
Effects of postmortem delay and temperature on neurotransmitter receptor binding in a rat model of the human autopsy process. J Neurochem (1984) 0.84
Alzheimer disease: plaques, tangles, and the basal forebrain. Ann Neurol (1982) 0.83
Cholinergic receptors in aging and Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry (1986) 0.83
Alzheimer's disease: a multisystem disorder. Res Publ Assoc Res Nerv Ment Dis (1986) 0.82
Corticotropin-releasing factor receptors in human pituitary gland: autoradiographic localization. Neuroendocrinology (1985) 0.82
Clinical trials in Alzheimer disease: debate on the use of placebo controls. Alzheimer Dis Assoc Disord (1999) 0.82
Laminar organization and age-related loss of cholinergic receptors in temporal neocortex of rhesus monkey. J Neurosci (1990) 0.82
Parkinson's disease: depletion of substantia nigra neurotensin receptors. Brain Res (1984) 0.81
A focus group on cognition-enhancing medications in Alzheimer disease: disparities between professionals and consumers. Alzheimer Dis Assoc Disord (2001) 0.81
Imagery and verbal encoding in left and right hemisphere damaged patients. Brain Lang (1981) 0.81
Immunohistochemical study of neurons containing corticotropin-releasing factor in Alzheimer's disease. Synapse (1987) 0.81
Neuropathology of aminergic nuclei in Alzheimer's disease. Prog Clin Biol Res (1989) 0.81
Twenty-four-hour rhythms of sleep-wake cycle and temperature in Alzheimer's disease. J Neuropsychiatry Clin Neurosci (2004) 0.80
Disturbances of person identification in Alzheimer's disease. A retrospective study. J Nerv Ment Dis (1992) 0.80
Assessment of functional ability in Alzheimer disease: a review and a preliminary report on the Cleveland Scale for Activities of Daily Living. Alzheimer Dis Assoc Disord (1992) 0.80
Neuroanatomical evidence for a cholinergic deficit in Alzheimer's disease. Psychopharmacol Bull (1983) 0.80
The beta amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives. Prog Clin Biol Res (1989) 0.79
The incompetent patient on the slippery slope. Hastings Cent Rep (1994) 0.79
Abnormalities in corticotropin-releasing hormone (CRH) in Alzheimer's disease and other human disorders. Ann N Y Acad Sci (1987) 0.79
Bilateral changes in neocortical [3H]pirenzepine and [3H]oxotremorine-M binding following unilateral lesions of the rat nucleus basalis magnocellularis: an autoradiographic study. Brain Res (1989) 0.79
Latent profile analysis of pelvic floor muscle pain in patients with chronic pelvic pain. Minerva Ginecol (2013) 0.79
Nicotinic cholinergic receptors associated with mammalian cerebral vessels. J Auton Nerv Syst (1994) 0.79
Alteration of phospholipase C-delta protein level and specific activity in Alzheimer's disease. J Neurochem (1995) 0.78
The end of Alzheimer disease. Alzheimer Dis Assoc Disord (2001) 0.78
Corticotropin-releasing hormone (CRH) is decreased in the basal ganglia in Huntington's disease. Brain Res (1987) 0.78
Multiple benzodiazepine receptors: autoradiographic localization in normal human amygdala. Brain Res (1983) 0.78
Psychiatric symptoms associated with Alzheimer's disease. J Neuropsychiatry Clin Neurosci (1990) 0.78
Neurobiological studies of transmitter systems in aging and in Alzheimer-type dementia. Ann N Y Acad Sci (1985) 0.77
Parkinson's disease: nigral receptor changes support peptidergic role in nigrostriatal modulation. Ann Neurol (1986) 0.77
Paying attention to acetylcholine: the key to wisdom and quality of life? Prog Brain Res (2004) 0.77
Neurotransmitter receptors in amyotrophic lateral sclerosis: possible relationship to sparing of eye movements. Ann Neurol (1985) 0.77
Concomitants of visual hallucinations in Alzheimer's disease. Neurology (1994) 0.77
The costs and social burdens of Alzheimer disease: what can and should be done? Alzheimer Dis Assoc Disord (1997) 0.77
The functional organization of the basal forebrain cholinergic system in primates and the role of this system in Alzheimer's disease. Ann N Y Acad Sci (1985) 0.77
Intraventricular bethanechol in Alzheimer's disease: a continuing controversy. Neurology (1988) 0.77
Aberrant phosphoinositide metabolism in Alzheimer's disease. Ann N Y Acad Sci (1993) 0.77
Dysfunction and death of neurons in human degenerative neurological diseases and in animal models. Ciba Found Symp (1987) 0.77
Huntington's disease: increased number and altered regulation of benzodiazepine receptor complexes in frontal cerebral cortex. Neurology (1987) 0.77